Table 1 Four pairs of agonists and antagonists of neuropathy-inducing drugs
From: Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events
Target | Agonists/antagonists | Drugs |
|---|---|---|
adrenergic receptor | agonists | 3: Tizanidine, Salmeterol, Salmeterol xinafoate |
antagonists | 7: Ziprasidone, Amiodarone, Amiodarone HCL, Propafenone, Betaxolol, Sotalol, Sotalol HCL | |
dopamine | agonists | 4: Bromocriptine, Pergolide, Pramipexole, Ropinirole |
antagonists | 2: Haloperidol, Ziprasidone | |
serotonin | agonists | 4: Almotriptan, Eletriptan, Sumatriptan, Zolmitriptan |
antagonists | 3: Alosetron, Cyproheptadine, Ziprasidone | |
hormone receptor | agonists | 5: Nevirapine, Megestrol, Dexamethasone, Fluticasone, Fluticasone propionate, |
antagonists | 2: Bicalutamide, Megestrol | |
modulators | 3. Leuprolide, Leuprolide acetate, Taxoxifen |